Jonathan Allan - Mar 15, 2025 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
GENERAL COUNSEL & CORP SEC
Signature
/s/ Jonathan Allan
Stock symbol
STOK
Transactions as of
Mar 15, 2025
Transactions value $
$0
Form type
4
Date filed
3/18/2025, 04:11 PM
Previous filing
Dec 11, 2024
Next filing
Mar 20, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STOK Common Stock Options Exercise $0 +7.48K +33.52% $0.00 29.8K Mar 15, 2025 Direct F1
transaction STOK Common Stock Options Exercise $0 +6K +20.15% $0.00 35.8K Mar 15, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Restricted Stock Units Options Exercise $0 -7.48K -33.33% $0.00 15K Mar 15, 2025 Common Stock 7.48K Direct F2, F3
transaction STOK Restricted Stock Units Options Exercise $0 -6K -25% $0.00 18K Mar 15, 2025 Common Stock 6K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported total includes an aggregate 825 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d).
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
F3 The award vested or vests as to 1/4 of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date.
F4 The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the issuer through each vesting date.